Literature DB >> 22441362

Hypersensitivity reactions during anesthesia. Results from the ninth French survey (2005-2007).

S W Dong1, P M Mertes, N Petitpain, F Hasdenteufel, J M Malinovsky.   

Abstract

BACKGROUND: Hypersensitivity reactions occurring during anesthesia remain a major cause of concern for anesthesiologists. We report the results of the ninth consecutive survey of hypersensitivity reactions observed during anesthesia in France. This report will be used as an epidemiologic reference prior to this intervention.
METHODS: Between January 1, 2005 to December 31, 2007, 1253 patients who experienced an immune-mediated (IgE-mediated) or non-immune-mediated (non-IgE-mediated) hypersensitivity reaction were referred to one of the 40 participating centers. Diagnosis was established on the basis of clinical history, skin tests and/or specific IgE assay.
RESULTS: An IgE-mediated or non-IgE-mediated reaction was diagnosed in 786 cases (63%) and 467 cases (37%), respectively. The most common causes of anaphylaxis were neuromuscular blocking agents (NMBA) (N.=373, 47.4%), latex (N.=158, 20%), and antibiotics (N.=141, 18.1%). Succinylcholine (N.=226, 60.6%) was the most frequently incriminated NMBA, whereas the low frequency of reactions involving cis-atracurium was confirmed (N.=22, 5.9%) when market shares of each NMBA were taken into account. An increased number of reactions involving vital dyes was recorded (N.=34, 4.4%).
CONCLUSION: These changes in the epidemiology of allergic reactions confirm the need for regular epidemiologic surveys of anaphylaxis in the perioperative period.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22441362

Source DB:  PubMed          Journal:  Minerva Anestesiol        ISSN: 0375-9393            Impact factor:   3.051


  21 in total

1.  Two cases of anaphylaxis under anaesthesia with vecuronium.

Authors:  Parli R Ravi; M N Vijay; Sachin Shouche
Journal:  Med J Armed Forces India       Date:  2013-12-16

Review 2.  Antibiotic Allergy in Pediatrics.

Authors:  Allison Eaddy Norton; Katherine Konvinse; Elizabeth J Phillips; Ana Dioun Broyles
Journal:  Pediatrics       Date:  2018-05       Impact factor: 7.124

Review 3.  Perioperative anaphylaxis: what should be known?

Authors:  Pascale Dewachter; Claudie Mouton-Faivre; David L Hepner
Journal:  Curr Allergy Asthma Rep       Date:  2015-05       Impact factor: 4.806

4.  Anaphylactic shock perioperative to patent blue dye.

Authors:  João Pedro Azevedo; Marta Alves; Carmelita Ribeiro; Ana Todo Bom
Journal:  BMJ Case Rep       Date:  2018-05-07

Review 5.  Exploring the link between pholcodine exposure and neuromuscular blocking agent anaphylaxis.

Authors:  Anna M Brusch; Russell C Clarke; Peter R Platt; Elizabeth J Phillips
Journal:  Br J Clin Pharmacol       Date:  2014-07       Impact factor: 4.335

Review 6.  Occupational Latex Allergy: the Current State of Affairs.

Authors:  Olivier Vandenplas; Monika Raulf
Journal:  Curr Allergy Asthma Rep       Date:  2017-03       Impact factor: 4.806

7.  Antibiotics Are the Most Commonly Identified Cause of Perioperative Hypersensitivity Reactions.

Authors:  James L Kuhlen; Carlos A Camargo; Diana S Balekian; Kimberly G Blumenthal; Autumn Guyer; Theresa Morris; Aidan Long; Aleena Banerji
Journal:  J Allergy Clin Immunol Pract       Date:  2016-03-30

8.  Required cefazolin concentration to maximize diagnostic accuracy of the basophil activation test for cefazolin-induced anaphylaxis.

Authors:  Tatsuo Horiuchi; Tomonori Takazawa; Masaki Orihara; Shinya Sakamoto; Akihiko Yokohama; Junko Takahashi; Akihiro Tomioka; Nagahide Yoshida; Kazuaki Hagiwara; Shigeru Saito
Journal:  J Anesth       Date:  2018-09-17       Impact factor: 2.078

Review 9.  Toxicities of opioid analgesics: respiratory depression, histamine release, hemodynamic changes, hypersensitivity, serotonin toxicity.

Authors:  Brian A Baldo
Journal:  Arch Toxicol       Date:  2021-05-11       Impact factor: 5.153

10.  Pharmacological interventions in acute respiratory distress syndrome.

Authors:  Antoine Roch; Sami Hraiech; Stéphanie Dizier; Laurent Papazian
Journal:  Ann Intensive Care       Date:  2013-07-03       Impact factor: 6.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.